Alkem Laboratories Limited (ALKEM) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.061x

Based on the latest financial reports, Alkem Laboratories Limited (ALKEM) has a cash flow conversion efficiency ratio of 0.061x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Rs8.37 Billion ≈ $90.47 Million USD) by net assets (Rs138.11 Billion ≈ $1.49 Billion USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See Alkem Laboratories Limited (ALKEM) balance sheet quality index to measure how much of total assets are equity-financed.

Alkem Laboratories Limited - Cash Flow Conversion Efficiency Trend (2010–2025)

This chart illustrates how Alkem Laboratories Limited's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check cash flow quality index of Alkem Laboratories Limited to evaluate the quality of earnings relative to operating cash generation.

Alkem Laboratories Limited Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Alkem Laboratories Limited ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Dutch Bros Inc NYSE:BROS	0.092x
Clearwater Analytics Holdings Inc NYSE:CWAN	0.009x
Hyatt Hotels Corporation NYSE:H	0.028x
Pepco Group B.V. WAR:PCO	0.834x
CAVA Group, Inc. NYSE:CAVA	0.052x
Yealink Network Technology Corp Ltd SHE:300628	0.055x
Multi Commodity Exchange of India Limited NSE:MCX	0.007x
Gigabyte Technology Co Ltd TW:2376	-0.049x

Annual Cash Flow Conversion Efficiency for Alkem Laboratories Limited (2010–2025)

The table below shows the annual cash flow conversion efficiency of Alkem Laboratories Limited from 2010 to 2025. For the full company profile with market capitalisation and key ratios, see market value of Alkem Laboratories Limited.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-03-31	Rs124.34 Billion ≈ $1.34 Billion	Rs19.13 Billion ≈ $206.87 Million	0.154x	-15.39%
2024-03-31	Rs107.14 Billion ≈ $1.16 Billion	Rs19.48 Billion ≈ $210.68 Million	0.182x	+1.96%
2023-03-31	Rs94.35 Billion ≈ $1.02 Billion	Rs16.82 Billion ≈ $181.96 Million	0.178x	+42.00%
2022-03-31	Rs88.47 Billion ≈ $956.81 Million	Rs11.11 Billion ≈ $120.15 Million	0.126x	-24.97%
2021-03-31	Rs75.58 Billion ≈ $817.37 Million	Rs12.65 Billion ≈ $136.79 Million	0.167x	+80.46%
2020-03-31	Rs63.09 Billion ≈ $682.29 Million	Rs5.85 Billion ≈ $63.27 Million	0.093x	-33.53%
2019-03-31	Rs55.72 Billion ≈ $602.59 Million	Rs7.77 Billion ≈ $84.07 Million	0.140x	+151.85%
2018-03-31	Rs49.85 Billion ≈ $539.14 Million	Rs2.76 Billion ≈ $29.87 Million	0.055x	-46.11%
2017-03-31	Rs45.83 Billion ≈ $495.62 Million	Rs4.71 Billion ≈ $50.95 Million	0.103x	-46.36%
2016-03-31	Rs37.87 Billion ≈ $409.55 Million	Rs7.26 Billion ≈ $78.50 Million	0.192x	+81.66%
2015-03-31	Rs30.85 Billion ≈ $333.60 Million	Rs3.25 Billion ≈ $35.20 Million	0.106x	-3.41%
2014-03-31	Rs26.55 Billion ≈ $287.14 Million	Rs2.90 Billion ≈ $31.37 Million	0.109x	+65.86%
2013-03-31	Rs23.74 Billion ≈ $256.72 Million	Rs1.56 Billion ≈ $16.91 Million	0.066x	+5.93%
2012-03-31	Rs19.06 Billion ≈ $206.08 Million	Rs1.18 Billion ≈ $12.81 Million	0.062x	-91.34%
2011-03-31	Rs11.67 Billion ≈ $126.25 Million	Rs8.38 Billion ≈ $90.62 Million	0.718x	+1128.81%
2010-03-31	Rs12.05 Billion ≈ $130.35 Million	Rs-840.93 Million ≈ $-9.09 Million	-0.070x	--

About Alkem Laboratories Limited

NSE:ALKEM India Drug Manufacturers - Specialty & Generic

Market Cap

$7.27 Billion

Rs671.96 Billion INR

Market Cap Rank

#2819 Global

#124 in India

Share Price

Rs5620.00

Change (1 day)

+0.40%

52-Week Range

Rs4844.50 - Rs5890.00

All Time High

Rs6366.25